Honestly, there is no reason for a delay anymore. Or there better not be I should say. They have a valution, Dawson has it, they better be working on it now and there is no reason for it not being moved forward, and everything on NGIO should be advancing to being listed.
I repeat, there is no reason for a delay anymore. From the words of Generex, everything has been handled, so it should be happening.
It's time to hold them to this one.
(4)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links